Home Celsius

Celsius

In operation
Series B
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Celsius Therapeutics, Inc. is a biotechnology company that develops precision medicines for cancer and autoimmune diseases using a platform based on human tissue. By leveraging single-cell genomics and machine learning to better understand the cellular ecosystem of diseases, the company has developed life-changing drugs and discovered key biomarkers for patient care.
Celsius Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2018
info@celsiustx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology Machine Learning
Concept
Disease Treatment Tumor Immune System Diseases Colorectal Cancer
Application Scenarios
Innovative Drugs AI+Pharmaceuticals